MiNK Therapeutics, Inc.INKTNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-1.35B
↓ 561% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
$-203.63M
Historical baseline
PeriodValueYoY Change
TTM$-1.35B-13976.9%
2024$-9.56M+39.4%
2023$-15.76M+16.5%
2022$-18.87M-47.1%
2021$-12.83M-53.8%
2020$-8.34M+44.2%
2019$-14.94M-